SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

Clinical trial NCT06384482 · UNKNOWN

Trial details

NCT number: NCT06384482
Sponsor: Shanghai Simnova Biotechnology Co.,Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma

Start date: 2024-04-30
Primary completion: 2025-04-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.